Online Supplement - The Lancet
358Ala with C-reactive protein (CRP; used as biomarker of target engagement for IL-6R) in this and other studies10 and (c) the effects of IL-6R blocking therapy on CRP (the most-widely used biomarker of target engagement for IL-6R blocking therapy) in randomized clinical trials of … ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.